ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Suven Life Sciences allotted 271,970 equity shares under its Employee Stock Option Scheme. The shares were admitted for trading on BSE and NSE effective July 3, 2026.
Suven Life Sciences granted 1,33,200 stock options at ₹55 per share under its 2020 ESOP scheme. Options vest over three years starting May 2027.